Close

EGRX Financial Facts

See Full Income Statement

See Full Balance Sheet

Eagle Pharmaceuticals (EGRX) Earnings

  |   Expand Research on EGRX
Next EPS Date 5/6/24 *Est. EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +2.4% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -9.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/28/24 Q423 N/A$1.07 N/A N/A$64.5M = N/A N/A
11/13/23 Q323 N/A$1.06 N/A N/A$62.6M = N/A N/A
11/6/23 Q323 N/A$1.06 N/A N/A$62.6M = N/A N/A
11/30/23 Q323 N/A$1.06 N/A N/A$62.6M = N/A N/A
12/29/23 Q323 N/A$1.09 N/A N/A$62.8M = N/A N/A
8/8/23 Q223 $1.18$1.07 +$0.11$64.6M$59.11M = Details
5/9/23 Q123 $1.26$0.93 +$0.33$66.3M$63.29M = Details
3/1/23 Q422 N/A$0.83 N/A N/A$64.26M N/A N/A N/A